Back to search results

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

IsraelRecruitingPHASE2, PHASE3

Conditions

Non-Squamous Non-Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ironwood Cancer and Research Centers - Chandler II /ID# 275443, Chandler, Arizona, United States

  • USC Norris Comprehensive Cancer Center /ID# 275343, Los Angeles, California, United States

  • Usc Norris Oncology/Hematology Treatment Center /ID# 278673, Newport Beach, California, United States

  • University Colorado Cancer Center /ID# 275382, Aurora, Colorado, United States

  • Mid Florida Hematology And Oncology Center /ID# 275278, Orange City, Florida, United States

  • Kaiser Permanente Moanalua Medical Center /ID# 275942, Honolulu, Hawaii, United States

  • The Iowa Clinic /ID# 276020, West Des Moines, Iowa, United States

  • Nho - Revive Research Institute /ID# 276115, Lincoln, Nebraska, United States

  • Renown Regional Medical Center /ID# 276049, Reno, Nevada, United States

  • Texas Oncology - South Austin /ID# 276033, Austin, Texas, United States

  • The University of Texas MD Anderson Cancer Center /ID# 275107, Houston, Texas, United States

  • Texas Oncology - Palestine Cancer Center /ID# 276034, Palestine, Texas, United States

  • Virginia Cancer Specialists - Fairfax /ID# 275071, Fairfax, Virginia, United States

  • University of Washington Medical Center /ID# 275866, Seattle, Washington, United States

  • Liverpool Hospital /ID# 276304, Liverpool, New South Wales, Australia

  • The Queen Elizabeth Hospital /ID# 275719, Woodville, South Australia, Australia

  • Austin Health /ID# 275505, Heidelberg, Victoria, Australia

  • St John Of God Murdoch Hospital /ID# 275700, Murdoch, Western Australia, Australia

  • Jessa Ziekenhuis - Campus Virga Jesse /ID# 275585, Hasselt, Limburg, Belgium

  • Universitair Ziekenhuis Leuven /ID# 275586, Leuven, Vlaams-Brabant, Belgium

  • AZ-Delta. /ID# 275753, Roeselare, West-Vlaanderen, Belgium

  • CHU de Liege /ID# 277971, Liège, Belgium

  • The Ottawa Hospital - General Campus /ID# 275611, Ottawa, Ontario, Canada

  • Princess Margaret Cancer Centre /ID# 274845, Toronto, Ontario, Canada

  • Rabin Medical Center. /ID# 274540, Petah Tikva, Central District, Israel

  • The Chaim Sheba Medical Center /ID# 274541, Ramat Gan, Tel Aviv, Israel

  • Rambam Health Care Campus- Haifa /ID# 274542, Haifa, Israel

  • IRCCS Istituti Fisioterapici Ospitalieri-Istituto Nazionale Tumori Regina Elena /ID# 274948, Rome, Roma, Italy

  • Azienda Ospedaliero Universitaria San Luigi Gonzaga /ID# 275215, Orbassano, Torino, Italy

  • Yokohama Municipal Citizen's Hospital /ID# 275682, Yokohama, Kanagawa, Japan

  • Niigata University Medical and Dental Hospital /ID# 275685, Niigata, Niigata, Japan

  • Osaka Medical And Pharmaceutical University Hospital /ID# 275684, Takatsuki, Osaka, Japan

  • Shizuoka Cancer Center /ID# 278082, Sunto-gun, Shizuoka, Japan

  • Juntendo University Hospital /ID# 276424, Bunkyo-ku, Tokyo, Japan

  • National Cancer Center Hospital /ID# 275678, Chuo-Ku, Tokyo, Japan

  • Unidade Local de Saude de Braga, EPE /ID# 275394, Braga, Portugal

  • Unidade Local de Saude de Santo Antonio /ID# 275387, Porto, Portugal

  • Hospital Cuf Porto /ID# 275395, Porto, Portugal

  • National Cancer Centre Singapore /ID# 275986, Singapore, Central Singapore, Singapore

  • National University Hospital /ID# 275988, Singapore, Singapore

  • Inje University Haeundae Paik Hospital /ID# 275388, Busan, Busan Gwang Yeogsi, South Korea

  • Chungbuk National University Hospital /ID# 275768, Cheongju-si, North Chungcheong, South Korea

  • Yonsei University Health System Severance Hospital /ID# 275384, Seoul, Seoul Teugbyeolsi, South Korea

  • Asan Medical Center /ID# 275600, Seoul, Seoul Teugbyeolsi, South Korea

  • Samsung Medical Center /ID# 278083, Seoul, Seoul Teugbyeolsi, South Korea

  • Hospital Clinic de Barcelona /ID# 275476, Barcelona, Spain

  • Hospital General Universitario Gregorio Maranon /ID# 275475, Madrid, Spain

  • Hospital Universitario 12 de Octubre /ID# 277698, Madrid, Spain

  • Instituto Valenciano de Oncología /ID# 275471, Valencia, Spain

  • Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 275293, Kaohsiung City, Taiwan

  • National Taiwan University Cancer Center (Ntucc) /ID# 275291, Taipei, Taiwan

  • Taipei Veterans General Hospital /ID# 275292, Taipei, Taiwan

Study leads

  • ABBVIE INC.

    Study Director

    AbbVie

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)